Next Article in Journal
Formulation Approaches for Improving the Dissolution Behavior and Bioavailability of Tolvaptan Using SMEDDS
Next Article in Special Issue
Development and Optimization of Nanolipid-Based Formulation of Diclofenac Sodium: In Vitro Characterization and Preclinical Evaluation
Previous Article in Journal
Discovery and Characterization of a New Crustin Antimicrobial Peptide from Amphibalanus amphitrite
Previous Article in Special Issue
Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(2), 414; https://doi.org/10.3390/pharmaceutics14020414
Action Date Notes Link
article xml file uploaded 14 February 2022 13:31 CET Original file -
article xml uploaded. 14 February 2022 13:31 CET Update https://www.mdpi.com/1999-4923/14/2/414/xml
article pdf uploaded. 14 February 2022 13:31 CET Version of Record https://www.mdpi.com/1999-4923/14/2/414/pdf
article html file updated 14 February 2022 13:32 CET Original file -
article html file updated 31 July 2022 17:35 CEST Update https://www.mdpi.com/1999-4923/14/2/414/html
Back to TopTop